Silver nanoparticles as a therapeutic agent in experimental cyclosporiasis
Authors:
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Experimental Parasitology
- Vol. 207, 107772
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- The Anti-Fasciolasis Properties of Silver Nanoparticles Produced by Trichoderma harzianum and Their Improvement of the Anti-Fasciolasis Drug TriclabendazoleInternational Journal of Molecular Sciences, 2013
- Interaction of silver nanoparticles with Escherichia coli and their cell envelope biomoleculesJournal of Basic Microbiology, 2013
- Low-dose cyclophosphamide-induced acute hepatotoxicityAmerican Journal of Case Reports, 2013
- Green synthesis of silver nanoparticles using carob leaf extract and its antibacterial activityInternational Journal of Industrial Chemistry, 2013
- Synthesis of silver nanoparticles using leaves of Catharanthus roseus Linn. G. Don and their antiplasmodial activitiesAsian Pacific Journal of Tropical Biomedicine, 2012
- Interferon-inducible effector mechanisms in cell-autonomous immunityNature Reviews Immunology, 2012
- Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agentsParasitology Research, 2012
- Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet lightInternational Journal of Nanomedicine, 2011
- Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetateParticle and Fibre Toxicology, 2011
- Update on Cyclospora cayetanensis , a Food-Borne and Waterborne ParasiteClinical Microbiology Reviews, 2010